These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26037113)

  • 21. Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates.
    Robinson RG; Smith SM; Wolkenberg SE; Kandebo M; Yao L; Gibson CR; Harrison ST; Polsky-Fisher S; Barrow JC; Manley PJ; Mulhearn JJ; Nanda KK; Schubert JW; Trotter BW; Zhao Z; Sanders JM; Smith RF; McLoughlin D; Sharma S; Hall DL; Walker TL; Kershner JL; Bhandari N; Hutson PH; Sachs NA
    ACS Chem Neurosci; 2012 Feb; 3(2):129-40. PubMed ID: 22860182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue and interspecies comparison of catechol-
    Jalkanen A; Lassheikki V; Torsti T; Gharib E; Lehtonen M; Juvonen RO
    Xenobiotica; 2021 Mar; 51(3):268-278. PubMed ID: 33289420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition.
    Laatikainen LM; Sharp T; Bannerman DM; Harrison PJ; Tunbridge EM
    J Psychopharmacol; 2012 Dec; 26(12):1561-8. PubMed ID: 22815336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolcapone improves cognition and cortical information processing in normal human subjects.
    Apud JA; Mattay V; Chen J; Kolachana BS; Callicott JH; Rasetti R; Alce G; Iudicello JE; Akbar N; Egan MF; Goldberg TE; Weinberger DR
    Neuropsychopharmacology; 2007 May; 32(5):1011-20. PubMed ID: 17063156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains.
    Swerdlow NR; Hines SR; Herrera SD; Weber M; Breier MR
    Pharmacol Biochem Behav; 2013 May; 106():128-31. PubMed ID: 23567203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity.
    Silva T; Mohamed T; Shakeri A; Rao PP; Martínez-González L; Pérez DI; Martínez A; Valente MJ; Garrido J; Uriarte E; Serrão P; Soares-da-Silva P; Remião F; Borges F
    J Med Chem; 2016 Aug; 59(16):7584-97. PubMed ID: 27463695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study.
    Ashare RL; Wileyto EP; Ruparel K; Goelz PM; Hopson RD; Valdez JN; Gur RC; Loughead J; Lerman C
    Drug Alcohol Depend; 2013 Dec; 133(3):852-6. PubMed ID: 24095246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase.
    Forester SC; Lambert JD
    Carcinogenesis; 2014 Feb; 35(2):365-72. PubMed ID: 24148818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex.
    Tunbridge EM; Bannerman DM; Sharp T; Harrison PJ
    J Neurosci; 2004 Jun; 24(23):5331-5. PubMed ID: 15190105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultraviolet B radiation differentially modifies catechol-O-methyltransferase activity in keratinocytes and melanoma cells.
    Magina S; Vieira-Coelho MA; Serrão MP; Kosmus C; Moura E; Moura D
    Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):137-41. PubMed ID: 22548395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution by monoamine oxidase and catechol-O-methyltransferase to the total-body and pulmonary plasma clearance of catecholamines.
    Friedgen B; Wölfel R; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):193-9. PubMed ID: 8717160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers.
    Magalona SC; Rasetti R; Chen J; Chen Q; Gold I; Decot H; Callicott JH; Berman KF; Apud JA; Weinberger DR; Mattay VS
    CNS Drugs; 2013 Aug; 27(8):663-73. PubMed ID: 23794107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The disposition of the tolcapone 3-O-methylated metabolite is affected by the route of administration in rats.
    Funaki T; Onodera H; Ushiyama N; Tsukamoto Y; Tagami C; Fukazawa H; Kuruma I
    J Pharm Pharmacol; 1994 Jul; 46(7):571-4. PubMed ID: 7996385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases.
    Lv X; Wang XX; Hou J; Fang ZZ; Wu JJ; Cao YF; Liu SW; Ge GB; Yang L
    Toxicol Appl Pharmacol; 2016 Jun; 301():42-9. PubMed ID: 27089846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of microtubule associated protein 2 and synaptophysin in endometrium: high levels in deep infiltrating endometriosis lesions.
    Gori M; Luddi A; Belmonte G; Piomboni P; Tosti C; Funghi L; Zupi E; Lazzeri L; Petraglia F
    Fertil Steril; 2016 Feb; 105(2):435-43. PubMed ID: 26604067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of catechol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons.
    Mercuri NB; Federici M; Bernardi G
    J Neural Transm (Vienna); 1999; 106(11-12):1135-40. PubMed ID: 10651109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats.
    Qi Q; Cao L; Li F; Wang H; Liu H; Hao H; Hao K
    Xenobiotica; 2015; 45(9):820-7. PubMed ID: 25869243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors.
    Bhakta SG; Light GA; Talledo JA; Balvaneda B; Hughes E; Alvarez A; Rana BK; Young JW; Swerdlow NR
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):979-987. PubMed ID: 29020372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex.
    Lapish CC; Ahn S; Evangelista LM; So K; Seamans JK; Phillips AG
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):521-30. PubMed ID: 18854987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.
    O'Tuathaigh CM; Clarke G; Walsh J; Desbonnet L; Petit E; O'Leary C; Tighe O; Clarke N; Karayiorgou M; Gogos JA; Dinan TG; Cryan JF; Waddington JL
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1331-42. PubMed ID: 22074909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.